Posts

Showing posts with the label Coronavirus

Whitepaper. The relationship between pharmaceutical stock trends and policy making for COVID-19 handling: correlations and causality that comprises integrity and effective treatment

Monitoring and evaluation: National Committee on US, China Relations (NCUSCR), Covid-19 policies

Risk Assessment of National Security Commission on Artificial Intelligence (NSCAI) mass-surveillance proposal in China-model adoptions vs. U.S. interests and national security